Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review
Simona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
Pharmacological Research (2018) Vol. 133, pp. 65-76
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Diagnosis and Pharmacotherapy of Alcohol Use Disorder
Henry R. Kranzler, Michael Soyka
JAMA (2018) Vol. 320, Iss. 8, pp. 815-815
Open Access | Times Cited: 485
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations
Paul Haber, Benjamin C. Riordan, Daniel T. Winter, et al.
The Medical Journal of Australia (2021) Vol. 215, Iss. S7
Closed Access | Times Cited: 69
Drug interactions in a sample of inpatients diagnosed with cannabis use disorder
Martin Schulze Westhoff, Christina Massarou, Stefan Bleich, et al.
Journal of Neural Transmission (2025)
Open Access | Times Cited: 1
Classics in Chemical Neuroscience: Baclofen
Caitlin N. Kent, Charlotte Park, Craig W. Lindsley
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 12, pp. 1740-1755
Closed Access | Times Cited: 63
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
David Prince, Emily Nash, Ken Liu
Drugs (2023) Vol. 83, Iss. 16, pp. 1459-1474
Open Access | Times Cited: 18
Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol
Fabio Caputo, Roberta Agabio, Teo Vignoli, et al.
Internal and Emergency Medicine (2018) Vol. 14, Iss. 1, pp. 143-160
Closed Access | Times Cited: 44
Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on Alcohol
Gianni Testino, Luigi Carlo Bottaro, Valentino Patussi, et al.
Minerva Medica (2018) Vol. 109, Iss. 5
Closed Access | Times Cited: 43
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.
Giovanni Addolorato, Hannu Alho, Paula B. M. de Andrade, et al.
European Journal of Internal Medicine (2024) Vol. 127, pp. 43-49
Open Access | Times Cited: 4
Alcohol use disorder and initiation of oral anticoagulant therapy in patients with atrial fibrillation: A nationwide cohort study
Miika Vanhanen, Jussi Jaakkola, Juhani Airaksinen, et al.
General Hospital Psychiatry (2025) Vol. 93, pp. 116-121
Closed Access
Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study.
Kannan Sridharan
Expert Opinion on Drug Safety (2025), pp. 1-16
Closed Access
Acute Ethanol-Disulfiram Reaction Presenting With Hemodynamic Instability: A Case Report
Marisa Santos, Francisca Carmo, João M. D. Miranda, et al.
Cureus (2025)
Open Access
The application of non-invasive brain stimulation techniques to reduce anger and violence proneness: results of a systematic review and meta-analysis
Ángel Romero‐Martínez, Carolina Sarrate‐Costa, Luis Moya‐Albiol
Journal of Psychiatric Research (2025)
Closed Access
GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
Weijie Xie, Yuan Li, Xinyue Wang, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Substance Use Disorders: Basic Overview for the Anesthesiologist
Federico Jimenez Ruiz, Nafisseh S. Warner, Gregory Acampora, et al.
Anesthesia & Analgesia (2023) Vol. 137, Iss. 3, pp. 508-520
Open Access | Times Cited: 9
Advantages and disadvantages of disulfiram coadministered with popular addictive substances
Patrycja Kleczkowska, Dorota Sulejczak, M Zaremba
European Journal of Pharmacology (2021) Vol. 904, pp. 174143-174143
Closed Access | Times Cited: 19
Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder
Nicolas Simon, Nicolas Franchitto, Benjamin Rolland
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 17
Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA)
Gianni Testino, Teo Vignoli, Valentino Patussi, et al.
Addiction Biology (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 13
<p>Pharmacogenetics of alcohol addiction: current perspectives</p>
Михаил Сергеевич Застрожин, Valentin Yurievich Skryabin, S. S. Miroshkin, et al.
The Application of Clinical Genetics (2019) Vol. Volume 12, pp. 131-140
Open Access | Times Cited: 12
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die
Maria Choví-Trull, Octavio Ballesta‐López, Gema Amparo Navarro Buendia, et al.
European Journal of Hospital Pharmacy (2024), pp. ejhpharm-004184
Closed Access | Times Cited: 1
Sodium oxybate: A comprehensive review of efficacy and safety in the treatment of alcohol withdrawal syndrome and alcohol dependence
Julien Guiraud, Wim van den Brink
International review of neurobiology (2024), pp. 213-281
Closed Access | Times Cited: 1
Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
Francesca Panin, Alessandra T. Peana
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 11
The Efficacy of Tiapride and Carbamazepine Combination Therapy in Reducing Alcohol Withdrawal Symptoms: A Systematic Review and Meta-Analysis
Sahar Latifi, Thomas Messer
Pharmacopsychiatry (2018) Vol. 52, Iss. 05, pp. 209-216
Open Access | Times Cited: 9
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA)
Gianni Testino, Teo Vignoli, Valentino Patussi, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 6, pp. 1975-1986
Open Access | Times Cited: 8
Mechanisms and Pharmacotherapy for Ethanol-Responsive Movement Disorders
Jingying Wu, Huidong Tang, Shengdi Chen, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 8
Multicomponent crystals of baclofen with acids and bases—conformational flexibility and synthon versatility
Ramokone Junia Malapile, Kudzanai Nyamayaro, Luigi R. Nassimbeni, et al.
CrystEngComm (2020) Vol. 23, Iss. 1, pp. 91-99
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top